American Health Council Names Nicholas Lange, Ph.D., MS to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
American Health Council Names Nicholas Lange, Ph.D., MS to Education Board

NEW YORK, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Nicholas Lange, Associate Professor of Psychiatry at Harvard Medical School, has been selected to join the Education Board at the American Health Council. He will be sharing his knowledge and expertise in the areas of Biostatistics, Brain Imaging, and Autism Research.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/Attachm...e01dfd3ab3

Dr. Lange’s continuing contributions to science over more than 30 years have been in the development and application of novel methodology for longitudinal and clustered data to investigate typical and atypical human and non-human brain development in psychotic disorders, spatial patterns of brain cells, and brain-behavior associations in autism.

Dr. Nicholas Lange, also a Biostatistician at McLean Hospital, has led and continues to lead multi-disciplinary teams of biostatisticians and other scientists that have made, and will continue to make, significant gains in the basic, translational, and clinical science of the developing human brain. McLean Hospital is the largest psychiatric affiliate of Harvard Medical School and a leader in scientific medical research and medical education.

Inspired by his early work with both children and adults with autism, Dr. Lange redirected his research program in the psychotic disorders to conduct various research studies of people on the autism spectrum. It is his continuing desire to foster high-quality biostatistical thinking, methods, and practice to further our understanding of the diagnosis, treatment, course, and outcome in autism and other mental disorders, with the overarching goal of improving the lives of individuals with mental illnesses and changing policy to increase funding from local, state, national, and international governments, institutions, private foundations, and private donations.

Dr. Lange regularly conducts multisite studies of brain development and concomitant psychophysical correlates in autism and searches for clinically relevant candidate intermediate phenotypes of the disorder. He has conducted a clinical trial of two early intervention programs in autism and an incipient clinical trial of ECT treatment for the elderly with major cognitive deficits and extreme anxiety.

Dr. Lange credits his success to his vision, persistence, hard work, and mentors who have taught and helped inspire him to reach his personal and professional goals. He is honored to have contributed to scientific knowledge regarding biology-based identification of those individuals who have been diagnosed with autism. Dr. Lange has been published in many theoretical and applied statistics and medical journals, opinion pieces (as in Nature on Imaging Autism ), and a variety of editorials.

His goals over the next five years include making major discoveries in brain-mind-behavior associations and causes in autism that significantly increase clinical utility and effectiveness for the individual with autism.

Dr. Lange’s many awards and honors include the Robert B. Reed Prize for Outstanding Scholarship, Harvard Biostatistics; Invited Article of the Year, Journal of the American Statistical Association; Invited Paper, Royal Statistical Society in (London), the first article on functional magnetic resonance imaging (fMRI) published in the statistical literature; and Certificate of Service and Appreciation, Journal of the American Academy of Child and Adolescent Psychiatry. He was appointed to a National Institutes of Health (NIH) Scientific Advisory Panel to evaluate the sites chosen for their nationwide early autism research network. Dr. Lange has also been included in the Marquis Who’s Who in Science and Engineering and the Marquis Who’s Who in America.

He is a member of the International Society for Autism Research. He also works with Autism Speaks and the National Institutes of Health.

Dr. Lange received his MS in Computer Science from the University of Massachusetts Amherst in 1981 and his PhD in Biostatistics from the Harvard University School of Public Health in 1986.

Dr. Nicholas Lange’s greatest personal achievement has been raising his children Sarah and Nick. He finds great joy in spending time with them and his four adorable granddaughters - Ella, Adeline, Isabel, and Meghan – and his amiguita Margarita. In his free time, Dr. Lange enjoys playing classical and rock guitar, traveling, learning more Spanish, philosophy and the philosophy of statistics, and early practice of Eastern Christianity.

For more information, please contact: Elizabeth Moore American Health Council Hauppauge, NY United States Phone: 1-212-390-0214 Email: media@americanhealthcouncil.org

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alley Cat Allies Pushes for Humane Cat Conservation Bill

Updated Category News Views 70

Time to Rethink Conservation: Save the Cats If you’re tuned into the chatter buzzing around the Cayman Islands, you know the clocks are ticking for a decision that could change the approach to handling community cats. Alley Cat Allies is waving the flag, urging the Cayman Islands Parliament to pass a bill that abandons the archaic practice of culling cats by shooting...

Continue Reading
Luxury Villa Cashback Offers Entice Travelers in November

Updated Category News Views 134

A November Bonanza for Villa Bookings Who doesn't love having a few extra bucks in their pocket, especially when they come with the allure of luxury travel? Villas of Distinction is rolling out what they call a 'November Cashback Offer,' and for those with the wallet—and wanderlust—to match, it could be a tempting proposition. Hanging the bait of up to $2,000 cashback...

Continue Reading
Duolingo Faces Class Action: Key Investor Steps

Updated Category News Views 126

Navigating Turbulent Times with Duolingo Holy moly, the dumpster fire that is the Duolingo (NASDAQ:DUOL) legal saga just got hotter. If you snagged yourself some shares between May 2, 2025, and February 26, 2026, you'd better sit down and grab some antacids—because the nauseating roller coaster is far from over. Robbins LLP is rounding up the troops for a class action,...

Continue Reading
Daymond John's Four-Center Bet on Longevity Game

Updated Category News Views 210

A Shark's Dive into Longevity Here you go—Daymond John, the face of FUBU and a household name from Shark Tank, is not just talking about living longer; he's putting his wallet where his words are. John is jumping into the longevity game with both feet, joining Ultimate Longevity Center's (ULC) latest venture. We're talking about four new centers across California,...

Continue Reading
Tenax Class Action: Investors Alley Fight for Redress

Updated Category News Views 144

Tenax Therapeutics in Hot Water Over Drug Trial Results Amidst the ever-unpredictable tides of the pharmaceutical industry, here comes a doozy – Tenax Therapeutics, Inc. is neck-deep in a shareholder lawsuit. If you tossed some money at NASDAQ:TENX anytime between November 13, 2023, and August 7, 2026, you might be feeling the sting of regret, and rightly so. What Went...

Continue Reading
Kinross Gold Fraud Lawsuit: What Shareholders Need to Know

Updated Category News Views 64

Kinross Gold's Legal Quagmire There's a fresh storm brewing for Kinross Gold Corporation (NYSE: KGC), and it ain't the kind investors enjoy riding. You see, the company is up to its neck in a class action lawsuit, courtesy of Schall, Brown & Schwartz LLP—a big-name shareholder rights litigation outfit. The gripe? Alleged securities fraud, violating §§10(b) and 20(a)...

Continue Reading
TCL Unveils Black Friday Steals on Smart Devices

Updated Category News Views 157

TCL's Big Move This Holiday Season When was the last time you saw a deal that actually made you stop and check your wallet? Well, TCL is giving you a reason to dig deep this Black Friday and Cyber Monday. They're slashing prices across smartphones and tablets, trying to elbow their way into your shopping cart with discounts up to $150. Now that's the kind of aggressive...

Continue Reading
Lilly Endowment Boosts Military Families with $10M Grant

Updated Category News Views 78

A Game-Changer for Semper Fi & America's Fund Dive in, folks. What we've got here is a hefty chunk of change — $10 million to be precise — dropped into Semper Fi & America's Fund's lap by Lilly Endowment Inc. We're talking about a grant designed to shore up the long-term support system crafted for the brave souls in military families. It’s about time a significant...

Continue Reading
Arbor Realty Trust Hit with Securities Fraud Lawsuit

Updated Category News Views 110

Snafu at Arbor Realty: Investors Rethink Strategies You know what puts a bee in my bonnet these days? Misleading statements from companies like Arbor Realty Trust, Inc. (NYSE: ABR). The news breaks that Arbor's got itself neck-deep in a class action lawsuit, courtesy of the sharp folks over at Schall, Brown & Schwartz LLP. Now, this ain't your average financial hiccup....

Continue Reading
LA Hospitals Shine in Pulmonary Excellence Nationwide

Updated Category News Views 150

Los Angeles Community Hospitals' Recent Recognition You ever stroll into a hospital and wonder if you’re really getting the best care? Well, the folks over at Los Angeles Community Hospitals, covering LA, Norwalk, and Bellflower, just got a big nod from Healthgrades—yeah, the site everyone's checking to find decent healthcare options. They’ve landed among the top...

Continue Reading

Top 5 Most Recently Viewed Articles

Vinanz Boosts Bitcoin Mining Operations with New Hardware

Updated Category News Views 160

Vinanz Limited Enhances Bitcoin Mining Capacity Vinanz Limited (US OTCQB: VINZF and AQSE: BTC) has taken a significant step forward in its operations by activating new Bitcoin mining hardware in Nebraska. This move aligns with its broader strategy to expand Bitcoin mining capabilities across North America. Introduction of Advanced Mining Technology The recent deployment...

Continue Reading
Recent Transparency Notification by Nyxoah - Key Insights

Updated Category News Views 202

Understanding Nyxoah's Recent Transparency Notification REGULATED INFORMATION Mont-Saint-Guibert – In alignment with disclosure requirements regarding shareholding changes, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) has announced an important transparency notification. Who is Vestal Point Capital? On October 23, Nyxoah disclosed that it received a transparency...

Continue Reading
Mural Oncology Set to Showcase Research at SITC Annual Meeting

Updated Category News Views 48

Mural Oncology Set to Showcase Research at SITC Annual Meeting Mural Oncology plc (NASDAQ: MURA), a pioneering company focused on immuno-oncology, is gearing up for a significant event—the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC). This important gathering will take place from November 6-10, 2024, in Houston, Texas. Mural Oncology is excited...

Continue Reading
Genmab A/S Announces Share Buyback Progress and Strategy

Updated Category News Views 128

Overview of Genmab's Share Buyback Program Genmab A/S has initiated an impressive share buyback program aimed at enhancing shareholder value. The program, announced on March 25, is designed to repurchase up to 2.2 million shares as part of its strategy to reduce capital and fulfill commitments under the Restricted Stock Unit program. Recent Transactions Under the Buyback...

Continue Reading